{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:28:54Z","timestamp":1780550934916,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd012619.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000}}],"reference-count":43,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012619.pub3","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:39:45Z","timestamp":1640198385000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Will","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Paediatric Respiratory Medicine; University Hospitals of the North Midlands; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Green","sequence":"additional","affiliation":[{"name":"Academic Department of Child Health; Royal Stoke University Hospital; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J","family":"Gilchrist","sequence":"additional","affiliation":[{"name":"Academic Department of Child Health; Royal Stoke University Hospital; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"10.1002\/14651858.CD012619.pub3-BIB0001|cit1","first-page":"138","article-title":"Effects of cisapride in patients with cystic fibrosis (CF) and chronic distal intestinal obstruction syndrome (DIOS)","volume":"Suppl 4","author":"Koletzko","year":"1989","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD012619.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3476(05)83350-5","article-title":"Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome","volume":"117","author":"Koletzko","year":"1990","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0003|cit3","first-page":"134","article-title":"Mucolytic treatment in cystic fibrosis. Double-blind clinical trial with oral acetylcysteine and placebo","volume":"61","author":"Baran","year":"1980","journal-title":"European Journal of Respiratory Diseases"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0004|cit4","unstructured":"Dalzell AM Heaf DP High dose pancreatic enzymes in distal intestinal obstruction syndrome Paediatric Research Society Meeting 1992 149"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0005|cit5","first-page":"135","article-title":"Results of oral acetylcysteine therapy in children with cystic fibrosis","volume":"61","author":"Dietzsch","year":"1980","journal-title":"European Journal of Respiratory Diseases"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0006|cit6","first-page":"122","article-title":"Oral acetylcysteine in cystic fibrosis. A co-operative study","volume":"111","author":"Gotz","year":"1980","journal-title":"European Journal of Respiratory Diseases. Supplement"},{"issue":"2","key":"10.1002\/14651858.CD012619.pub3-BIB0007|cit7","first-page":"82","article-title":"A double-blind study of the use of acetylcysteine in patients with cystic fibrosis","volume":"32","author":"Howatt","year":"1966","journal-title":"University of Michigan Medical Center Journal"},{"issue":"3","key":"10.1002\/14651858.CD012619.pub3-BIB0008|cit8","first-page":"207","article-title":"Failure of oral N-acetylcysteine to improve the malabsorption of cystic fibrosis","volume":"17","author":"Mitchell","year":"1981","journal-title":"Australian Paediatric Journal"},{"issue":"9","key":"10.1002\/14651858.CD012619.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1345\/aph.1Q219","article-title":"Lubiprostone for constipation in adults with cystic fibrosis: a pilot study","volume":"45","author":"O'Brien","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012619.pub3-BIB0010|cit10","first-page":"Abstract no. A2","article-title":"Treatment of distal intestinal obstruction syndrome (DIOS) in cystic fibrosis: proposal of a multicenter protocol","volume":"45","author":"Rotolo","year":"2019","journal-title":"Italian Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012619.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"Alton","year":"2017","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD012619.pub3-BIB0012|cit12","first-page":"355","article-title":"The age-related incidence of meconium ileus equivalent in a cystic fibrosis population:the impact of a high energy intake","volume":"11","author":"Andersen","year":"1990","journal-title":"Journal of Paediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0013|cit13","volume-title":"British National Formulary for Children","volume":"72","author":"Joint Formulary Committee","year":"2016"},{"issue":"4","key":"10.1002\/14651858.CD012619.pub3-BIB0014|cit14","first-page":"220","article-title":"What is the role of prokinetics for constipation","volume":"58","author":"Boyle","year":"2009","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0015|cit15","unstructured":"CF Foundation About Cystic Fibrosis www.cff.org\/What-is-CF\/About-Cystic-Fibrosis\/"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-13-211","article-title":"A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Health Service Research"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10 Suppl 2","author":"Colombo","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"7","key":"10.1002\/14651858.CD012619.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/thx.42.7.538","article-title":"Distal intestinal obstruction syndrome in cystic fibrosis treated by oral intestinal lavage, and a case of recurrent obstruction despite normal pancreatic function","volume":"42","author":"Davidson","year":"1987","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0019|cit19","unstructured":"Deeks J Higgins J Altman D editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD012619.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1542-3565(04)00169-7","article-title":"Distal intestinal obstruction syndrome in adults with cystic fibrosis","volume":"2","author":"Dray","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012619.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"7256","key":"10.1002\/14651858.CD012619.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.321.7256.259","article-title":"UK licence for cisapride suspended","volume":"321","author":"Ferriman","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012619.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.123.1.37","article-title":"Gastrointestinal complications after lung transplantation in patients with cystic fibrosis","volume":"123","author":"Gilljam","year":"2003","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0024|cit24","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD012619.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"Journal of Paediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD012619.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1651-2227.1995.tb13699.x","article-title":"Cystic fibrosis, pancreatic sufficiency and distal intestinal obstruction syndrome: a report of four cases","volume":"84","author":"Millar-Jones","year":"1995","journal-title":"Acta Paediatrica"},{"issue":"7","key":"10.1002\/14651858.CD012619.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012619.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcf.2016.02.002","article-title":"International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: associated factors and outcome","volume":"15","author":"Munck","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0029|cit29","unstructured":"National Institute for Healthcare and Excellence (NICE) Clinical knowledge summaries. Constipation in children (last revised June 2015) cks.nice.org.uk\/constipation-in-children#!scenario"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0030|cit30","unstructured":"National Institute for Healthcare and Excellence (NICE) Clinical knowledge summaries. Constipation (last revised June 2017) https:\/\/cks.nice.org.uk\/constipation#!prescribinginfosub:2"},{"issue":"7","key":"10.1002\/14651858.CD012619.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/thx.42.7.526","article-title":"Cystic fibrosis in adolescents and adults","volume":"42","author":"Penketh","year":"1987","journal-title":"Thorax"},{"issue":"18","key":"10.1002\/14651858.CD012619.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0033|cit33","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"4","key":"10.1002\/14651858.CD012619.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2017","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Rubinstein S Moss R Lewiston N Constipation and meconium ileus equivalent in patients with cystic fibrosis Pediatrics 1986 78 3 473 9","DOI":"10.1542\/peds.78.3.473"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1478-4505-4-25","article-title":"Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation","volume":"4","author":"Schunemann","year":"2006","journal-title":"Health Research Policy & Systems"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0037|cit37","unstructured":"Sterne JAC Egger M Moher D editor(s) on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0038|cit38","volume-title":"Essential Medical Genetics","author":"Tobias","year":"2011"},{"issue":"4-5","key":"10.1002\/14651858.CD012619.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/phrs.1996.0030","article-title":"Recent advances in the pharmacology of gastrointestinal prokinetics","volume":"33","author":"Tonni","year":"1996","journal-title":"Pharmacological Research"},{"issue":"7","key":"10.1002\/14651858.CD012619.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1742-1241.1999.tb11803.x","article-title":"Oral gastrografin in neonates: a note of caution","volume":"53","author":"Tuladhar","year":"1999","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD012619.pub3-BIB0041|cit41","unstructured":"Orkambi\u2122 (lumacaftor\/ivacaftor) [prescribinginformation] www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm505856.htm"},{"issue":"1","key":"10.1002\/14651858.CD012619.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2009.11.003","article-title":"Constipation in paediatric cystic fibrosis patients: an underestimated medical condition","volume":"9","author":"Van der Doef","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD012619.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11894-011-0185-9","article-title":"Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation","volume":"13","author":"Van der Doef","year":"2011","journal-title":"Current Gastroenterology Reports"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:33:14Z","timestamp":1683077594000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012619.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012619.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]}}}